Patents by Inventor Mark Seefeld

Mark Seefeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted Pyrazolopyridines
    Publication number: 20250051363
    Abstract: Disclosed herein are substituted pyrazolopyridines, methods for their preparation, and use thereof.
    Type: Application
    Filed: August 2, 2024
    Publication date: February 13, 2025
    Inventors: Mark Seefeld, Zheng Li, Xinyan Huang
  • Antibacterial Agents
    Publication number: 20080234256
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: January 24, 2006
    Publication date: September 25, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20080009483
    Abstract: Napthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed.
    Type: Application
    Filed: January 24, 2006
    Publication date: January 10, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Miller, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20070287701
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: June 15, 2005
    Publication date: December 13, 2007
    Inventors: William Miller, Israil Pendrak, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20070270417
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 21, 2005
    Publication date: November 22, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20070254872
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 8, 2005
    Publication date: November 1, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20070244091
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: August 2, 2005
    Publication date: October 18, 2007
    Inventors: William Miller, Mark Seefeld
  • Antibacterial Agents
    Publication number: 20070203127
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 13, 2005
    Publication date: August 30, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Jeffrey Axten, Mark Seefeld
  • Antibacterial agents
    Publication number: 20070161627
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: August 9, 2005
    Publication date: July 12, 2007
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Antibacterial agents
    Publication number: 20070004710
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: November 4, 2003
    Publication date: January 4, 2007
    Inventors: Jeffrey Axten, Timothy Gallagher, William Miller, Mark Seefeld
  • Antibacterial agents
    Publication number: 20060189601
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: March 26, 2004
    Publication date: August 24, 2006
    Inventors: Alan Hennessy, William Miller, Mark Seefeld
  • Fab I inhibitors
    Publication number: 20060116394
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Application
    Filed: November 22, 2005
    Publication date: June 1, 2006
    Inventors: Walter Burgess, Dalia Jakas, William Huffman, William Miller, Kenneth Newlander, Mark Seefeld, Irene Uzinskas
  • Antibacterial agents
    Publication number: 20060041123
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: December 17, 2003
    Publication date: February 23, 2006
    Inventors: Jeffrey Axten, Gerald Brooks, Pamela Brown, David Davies, Timothy Gallagher, Roger Markwell, William Miller, Neil Pearson, Mark Seefeld
  • Antibacterial compounds
    Patent number: 6964970
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections: wherein: R1 is Ar or Het; R2 is H, C1-6alkyl or Ar-C0-6alkyl; X is H, C1-4alkyl, OR?, SR?, C1-4alkylsulfonyl, C1-4alkylsulfoxyl, CN, N(R?)2, CH2N(R?) 2, NO2, CF3, CO2R?, CON(R?)2, COR?, NR?C(O)R?, F, Cl, Br, I, or CF3S(O)r—; R? is H, C1-6alkyl or Ar-C0-6alkyl; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: November 15, 2005
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark Seefeld
  • FAB I inhibitors
    Publication number: 20050250810
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Application
    Filed: December 9, 2004
    Publication date: November 10, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: William Miller, Kenneth Newlander, Mark Seefeld, Irene Uzinskas, Walter DeWolf, Dalia Jakas
  • Aminopiperidine derivatives
    Publication number: 20050159411
    Abstract: Piperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.
    Type: Application
    Filed: January 27, 2003
    Publication date: July 21, 2005
    Inventors: Robert Daines, William Miller, Neil Pearson, Israil Pendrak, Mark Seefeld
  • Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
    Publication number: 20050085494
    Abstract: Aminopiperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.
    Type: Application
    Filed: January 27, 2003
    Publication date: April 21, 2005
    Inventors: Robert Daines, William Miller, Neil Pearson, Israil Pendrak, Mark Seefeld
  • Antibacterial compounds
    Publication number: 20030232850
    Abstract: Compounds of formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections, wherein: R1 is Ar or Het; R2 is H, C1-6alkyl or Ar—C0-6alkyl; X is H, C1-4alkyl, OR′, SR′, C1-4alkylsulfonyl, C1-4alkylsulfonyl, CN, N(R′)2, CH2N(R′)2, NO2, CF3, CO2R′, CON(R′)2, COR′, NR′C(O)R′, F, Cl, Br, I, or CF3S(O)r; R′ is H, C1-6alkyl or Ar—C0-6alkyl; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 5, 2003
    Publication date: December 18, 2003
    Inventors: William H. Miller, Kenneth A. Newlander, Mark Seefeld
  • Antibacterial compounds
    Patent number: 6573272
    Abstract: Compounds of the formula (I) are disclosed which are FabI inhibitors and are useful in the treatment bacterial infections: wherein: R1 is Ar or Het; R2 is H, C1-6alkyl or Ar—C0-6alkyl; X is H, C1-4alkyl, OR′, SR′, C1-4alkylsulfonyl, C1-4alkylsulfoxyl, CN, N(R′)2, CH2N(R′)2, NO2, CF3, CO2R′, CON(R′)2, COR′, NR′C(O)R′, F, Cl, Br, I, or CF3S(O)r—; R′ is H, C1-6alkyl or Ar—C0-6alkyl; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: June 3, 2003
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark Seefeld